Module 2: Vaccine-Preventable Pneumonia Series: Pneumococcal vaccination in populations at high risk for invasive disease

Vaccine-Preventable Pneumonia Series: Evaluating the clinical evidence of the utility of a newly available 15-valent pneumococcal conjugate vaccine for patients at high risk for invasive disease
Learning objectives
You will learn:
- The current Streptococcus pneumoniae morbidity and mortality burden in South Africa Factors that increase the risk for S. pneumoniae infections and invasive pneumococcal disease (IPD)
- South African recommendations for pneumococcal vaccination in children and adults, including those with risk factors for IPD
- Clinical evidence supporting the utility of a newly available 15-valent pneumococcal conjugate vaccine in paediatric and adult populations at risk for IPD in South Africa.
To access this module, please register or login:
